Findings

What do systematic reviews say?

1,822 questions · 1,891 findings · 321 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 279 · 14.8%GRADE not reported 46 · 2.4%Very low 524 · 27.7%Low 571 · 30.2%Moderate 330 · 17.5%High 141 · 7.5%

Intervention not reported

Pitavastatin dose · participants with normal or abnormal lipid profiles

The review found no eligible studies for this question.

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 673 participants
High

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
26 studies · 2035 participants
High

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 424 participants
High

Intervention not reported

CI: Confidence interval · participants with normal or abnormal lipid profiles

The review found no eligible studies for this question.

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

aMean baseline values. · participants with normal or abnormal lipid profiles

The review found no eligible studies for this question.

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 759 participants
High

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
36 studies · 3847 participants
High

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 469 participants
High

Intervention not reported

CI: Confidence interval · participants with normal or abnormal lipid profiles

The review found no eligible studies for this question.

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

aMean baseline values. · participants with normal or abnormal lipid profiles

The review found no eligible studies for this question.

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Pitavastatin dose · participants with normal or abnormal lipid profiles

The review found no eligible studies for this question.

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 777 participants
High

Intervention not reported

mg/day · participants with normal or abnormal lipid profiles

1 finding from 1 review

Pitavastatin for lowering lipids 2020 · Cochrane Headline outcomes only
no estimate extracted
32 studies · 2789 participants
High

BoNT‐A vs usual care or physiotherapy

Instrumented gait analysis (kinematics) (not measured) · children with CP

The review found no eligible studies for this question.

3 findings from 1 review

Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

BoNT‐A vs usual care or physiotherapy

Function · children with CP

3 findings from 1 review

Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 191 participants
Very low
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 199 participants
Very low
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 123 participants
Very low

BoNT‐A vs usual care or physiotherapy

Range of motion (passive ankle dorsiflexion) · children with CP

3 findings from 1 review

Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 272 participants
Very low
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 250 participants
Very low
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 186 participants
Very low

BoNT‐A vs usual care or physiotherapy

Satisfaction (not measured) · children with CP

The review found no eligible studies for this question.

2 findings from 1 review

Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

BoNT‐A vs usual care or physiotherapy

Spasticity (ankle plantarflexors) · children with CP

3 findings from 1 review

Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 226 participants
Very low
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 258 participants
Very low
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 186 participants
Very low

BoNT‐A vs usual care or physiotherapy

Adverse events · children with CP

The review found no eligible studies for this question.

3 findings from 1 review

Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy 2019 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 206 participants
Very low